InsidersTradesSigma
Track the Ocumension Therapeutics - B stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, Ocumension Therapeutics - B has published 6 insider filings. Market capitalisation: €4.1bn. The latest transaction was disclosed on 3 July 2026 (Sale). Among the most active insiders: Hu Zhaopeng. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ocumension Therapeutics - B Buy (bullish), based on 2 analysts. Average price target: HK$9.59.
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,904 of 29,064 companies
26.2
score / 100
Value20
Quality32
FCF yld-8.6%
Earn yld-3.8%
EV/EBITDA·
ROE-3.4%
Gross mgn45%
Net mgn-20%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations6 total
742 sharesShareXHKGHKEX:DA20260702E00734
2,700 sharesShareXHKGHKEX:DA20260702E00733
13,700 sharesShareXHKGHKEX:DA20260618E00004
1,648 sharesShareXHKGHKEX:DA20260618E00003
140,000 sharesShareXHKGHKEX:DA20260618E00002
6 of 6 declarations
关于 Ocumension Therapeutics - B
欧康维视生物-B是一家专注于开发眼科治疗方法的公司。它强调医疗保健和制药领域的创新。